Market Segment: HealthCare Specialties Niche ETFs
Evaluating Niche ETFs
Overview
ALPS Medical Breakthroughs ETF
Targets biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials that are U.S. listed.
| Exchange Listing | NYSE |
| Niche ETF – Category | Innovation |
| Niche ETF – Market Segment | Healthcare Specialties |
| Inception Date | 12/30/14 |
| Number of Holdings | 109 |
| Rebalancing Schedule | t.b.d. |
| Weighting Method | Cap Weighted |
| Management Style | Passive |
| Tactic | Smart Beta |
| Factors | Multi-factor |
Additional information regarding the ETF‘s performance, pricing, NAV, trading volume, AUM, exposures and fee structure can be located by clicking on the PERFORMANCE button at the top of the page for this fund.
Poliwogg Medical Breakthroughs Index
By clicking on the above link, you will be leaving NicheETFs.com.
Disclosure
NicheETFs.com does not promote, issuer or endorse the content of this information or guarantee it’s accuracy for the purposes of making any investment decisions. It is solely for general information purposes and should not be relied upon when making investment decisions without consulting an investment, financial or tax professional. NicheETFs.com makes no representations about the suitability of the information, products or services presented, nor of those of any issuer links. Past performance is not indicative of future results.
Share This Niche ETF, Choose a Platform!
Innovation Sub-Segments
Impact Sub-Segments
Infrastructure Sub-Segments
Advertisement Space